60 Degrees Pharmaceuticals reports 25,000 U.S. adults claim babesiosis-related medical costs annually, highlighting chronic fatigue as a potential symptom. Highlights significant discrepancy between ...
View 60 Degrees Pharmaceuticals, Inc. SXTP stock quote prices, financial information, real-time forecasts, and company news from CNN.
Travelers can now purchase the only once-weekly, broad-spectrum malaria preventive online, through the Runway Health ...
60 Degrees Pharmaceuticals Inc. (SXTP) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
A survey suggests babesiosis cases in the U.S. may be significantly underreported, with millions experiencing chronic fatigue linked to the disease. A recent survey by 60 Degrees Pharmaceuticals, Inc.
WASHINGTON, Feb. 20, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals (SXTP), Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious ...
WASHINGTON, March 11, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees" or the "Company"), a pharmaceutical company focused on developing new medicines for ...
WASHINGTON, Jan. 22, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees Pharma" or the "Company"), a pharmaceutical company focused on developing new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results